tiprankstipranks
Solvonis Therapeutics plc (GB:SVNS)
LSE:SVNS
UK Market
Want to see GB:SVNS full AI Analyst Report?

Solvonis Therapeutics (SVNS) Financial Statements

13 Followers

Solvonis Therapeutics Financial Overview

Solvonis Therapeutics's market cap is currently £16.68M. The company's EPS TTM is p-0.01; its P/E ratio is -2.63; Solvonis Therapeutics is scheduled to report earnings on April 29, 2026, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 0.00£ 0.00£ 587.00K£ 542.00K£ 219.00K
Gross Profit£ 0.00£ 0.00£ -134.00K£ -51.00K£ 55.00K
Operating Income£ -3.48M£ -1.38M£ -3.12M£ -2.71M£ -845.00K
EBITDA£ -5.74M£ -1.38M£ -2.94M£ -2.59M£ -900.00K
Net Income£ -5.74M£ -1.59M£ -3.12M£ -2.71M£ -954.00K
Balance Sheet
Cash & Short-Term Investments£ 1.72M£ 757.00K£ 155.00K£ 1.64M£ 598.00K
Total Assets£ 7.58M£ 3.20M£ 2.43M£ 4.94M£ 3.13M
Total Debt£ 75.00K£ 0.00£ 34.00K£ 22.00K£ 950.00K
Net Debt£ -1.65M£ -757.00K£ -121.00K£ -1.62M£ 352.00K
Total Liabilities£ 1.39M£ 119.00K£ 408.00K£ 385.00K£ 2.32M
Stockholders' Equity£ 6.19M£ 3.08M£ 2.03M£ 4.55M£ 812.00K
Cash Flow
Free Cash Flow£ -3.27M£ -1.13M£ -1.47M£ -3.08M£ -255.00K
Operating Cash Flow£ -3.27M£ -1.13M£ -1.24M£ -2.36M£ -254.00K
Investing Cash Flow£ 0.00£ -337.00K£ -232.00K£ -718.00K£ -1.00K
Financing Cash Flow£ 4.23M£ 2.08M£ 0.00£ 4.13M£ 800.00K
Currency in GBP

Solvonis Therapeutics Earnings and Revenue History

Solvonis Therapeutics Debt to Assets

Solvonis Therapeutics Cash Flow

Solvonis Therapeutics Forecast EPS vs Actual EPS